NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.

<h4>Background</h4>Plasminogen activator inhibitor 1 (PAI-1) is a key regulator of the plasminogen activation system. Although several lines of evidence support a significant role of PAI-1 in the brain, the regulation of its expression in neurons is poorly understood. In the present stud...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Georgios C Stefos, Ulf Soppa, Mara Dierssen, Walter Becker
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/ecca820e8e7547649bcd68aa835e0553
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ecca820e8e7547649bcd68aa835e0553
record_format	dspace
spelling	oai:doaj.org-article:ecca820e8e7547649bcd68aa835e05532021-11-18T07:40:03ZNGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.1932-620310.1371/journal.pone.0067470https://doaj.org/article/ecca820e8e7547649bcd68aa835e05532013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23825664/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Plasminogen activator inhibitor 1 (PAI-1) is a key regulator of the plasminogen activation system. Although several lines of evidence support a significant role of PAI-1 in the brain, the regulation of its expression in neurons is poorly understood. In the present study we tested the hypothesis that NGF induces the upregulation of PAI-1 via the calcineurin/nuclear factor of activated T cells (NFAT) pathway and analysed whether the overexpression of the Down syndrome-related proteins DYRK1A and RCAN1 modulated the effect of NGF on PAI-1 expression.<h4>Results</h4>NGF upregulated PAI-1 mRNA levels in primary mouse hippocampal neurons cultured for 3 days in vitro and in the rat pheochromocytoma cell line PC12. Reporter gene assays revealed that NGF activated the calcineurin/NFAT pathway in PC12 cells. Induction of PAI-1 by NGF was sensitive to the calcineurin inhibitor FK506 and the specific inhibition of NFAT activation by the cell permeable VIVIT peptide. Activation of calcineurin/NFAT signalling through other stimuli resulted in a much weaker induction of PAI-1 expression, suggesting that other NGF-induced pathways are involved in PAI-1 upregulation. Overexpression of either DYRK1A or RCAN1 negatively regulated NFAT-dependent transcriptional activity and reduced the upregulation of PAI-1 levels by NGF.<h4>Conclusion</h4>The present results show that the calcineurin/NFAT pathway mediates the upregulation of PAI-1 by NGF. The negative effect of DYRK1A and RCAN1 overexpression on NGF signal transduction in neural cells may contribute to the altered neurodevelopment and brain function in Down syndrome.Georgios C StefosUlf SoppaMara DierssenWalter BeckerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 6, p e67470 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Georgios C Stefos Ulf Soppa Mara Dierssen Walter Becker NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
description	<h4>Background</h4>Plasminogen activator inhibitor 1 (PAI-1) is a key regulator of the plasminogen activation system. Although several lines of evidence support a significant role of PAI-1 in the brain, the regulation of its expression in neurons is poorly understood. In the present study we tested the hypothesis that NGF induces the upregulation of PAI-1 via the calcineurin/nuclear factor of activated T cells (NFAT) pathway and analysed whether the overexpression of the Down syndrome-related proteins DYRK1A and RCAN1 modulated the effect of NGF on PAI-1 expression.<h4>Results</h4>NGF upregulated PAI-1 mRNA levels in primary mouse hippocampal neurons cultured for 3 days in vitro and in the rat pheochromocytoma cell line PC12. Reporter gene assays revealed that NGF activated the calcineurin/NFAT pathway in PC12 cells. Induction of PAI-1 by NGF was sensitive to the calcineurin inhibitor FK506 and the specific inhibition of NFAT activation by the cell permeable VIVIT peptide. Activation of calcineurin/NFAT signalling through other stimuli resulted in a much weaker induction of PAI-1 expression, suggesting that other NGF-induced pathways are involved in PAI-1 upregulation. Overexpression of either DYRK1A or RCAN1 negatively regulated NFAT-dependent transcriptional activity and reduced the upregulation of PAI-1 levels by NGF.<h4>Conclusion</h4>The present results show that the calcineurin/NFAT pathway mediates the upregulation of PAI-1 by NGF. The negative effect of DYRK1A and RCAN1 overexpression on NGF signal transduction in neural cells may contribute to the altered neurodevelopment and brain function in Down syndrome.
format	article
author	Georgios C Stefos Ulf Soppa Mara Dierssen Walter Becker
author_facet	Georgios C Stefos Ulf Soppa Mara Dierssen Walter Becker
author_sort	Georgios C Stefos
title	NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
title_short	NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
title_full	NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
title_fullStr	NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
title_full_unstemmed	NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.
title_sort	ngf upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/nfat pathway and the down syndrome-related proteins dyrk1a and rcan1 attenuate this effect.
publisher	Public Library of Science (PLoS)
publishDate	2013
url	https://doaj.org/article/ecca820e8e7547649bcd68aa835e0553
work_keys_str_mv	AT georgioscstefos ngfupregulatestheplasminogenactivationinhibitor1inneuronsviathecalcineurinnfatpathwayandthedownsyndromerelatedproteinsdyrk1aandrcan1attenuatethiseffect AT ulfsoppa ngfupregulatestheplasminogenactivationinhibitor1inneuronsviathecalcineurinnfatpathwayandthedownsyndromerelatedproteinsdyrk1aandrcan1attenuatethiseffect AT maradierssen ngfupregulatestheplasminogenactivationinhibitor1inneuronsviathecalcineurinnfatpathwayandthedownsyndromerelatedproteinsdyrk1aandrcan1attenuatethiseffect AT walterbecker ngfupregulatestheplasminogenactivationinhibitor1inneuronsviathecalcineurinnfatpathwayandthedownsyndromerelatedproteinsdyrk1aandrcan1attenuatethiseffect
_version_	1718423135264440320

NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.

Ejemplares similares